Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,507,698
  • Shares Outstanding, K 371,224
  • Annual Sales, $ 60,210 K
  • Annual Income, $ -514,020 K
  • 60-Month Beta 0.69
  • Price/Sales 454.77
  • Price/Cash Flow N/A
  • Price/Book 14.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.44
  • Number of Estimates 6
  • High Estimate -0.14
  • Low Estimate -0.95
  • Prior Year -0.37
  • Growth Rate Est. (year over year) -18.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.80 +12.87%
on 07/13/20
95.21 -24.37%
on 07/17/20
+9.40 (+15.01%)
since 07/10/20
3-Month
46.13 +56.10%
on 05/27/20
95.21 -24.37%
on 07/17/20
+12.76 (+21.54%)
since 05/08/20
52-Week
12.47 +477.47%
on 08/15/19
95.21 -24.37%
on 07/17/20
+58.68 (+440.21%)
since 08/09/19

Most Recent Stories

More News
John Lepore Joins Moderna as Senior Vice President, Government Engagement

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that...

MRNA : 72.01 (-2.82%)
MA : 322.88 (-1.57%)
RELX : 22.15 (-0.05%)
GSK : 40.94 (+0.37%)
5 Stocks in the Spotlight on Trump's Coronavirus Vaccine Optimism

Millions are pinning their hopes on a handful of drugmakers, which are into the final phases of their vaccine trial.

SNY : 50.91 (-1.16%)
DVAX : 7.79 (+0.13%)
PFE : 38.39 (-0.16%)
GILD : 68.51 (-1.21%)
MRNA : 72.01 (-2.82%)
LLY : 153.00 (+0.05%)
GSK : 40.94 (+0.37%)
AMGN : 238.17 (-1.05%)
ADPT : 37.60 (-1.62%)
BNTX : 73.95 (-3.96%)
3 of David Tepper's Largest Holdings

David Tepper is a world renown hedge fund manager. Following top hedge fund managers can lead to fruitful returns. So here are the top holdings in Tepper's Appaloosa portfolio: Amazon.com (AMZN), Alibaba...

AMZN : 3,148.16 (-0.61%)
BABA : 248.13 (-1.57%)
GOOGL : 1,496.82 (-0.10%)
MRNA : 72.01 (-2.82%)
GPN : 170.26 (-2.61%)
SBUX : 77.47 (+2.22%)
ADT : 11.93 (-2.21%)
Moderna (MRNA) Q2 Earnings and Revenues Surpass Estimates

Moderna (MRNA) reports narrower-than-expected second-quarter loss. Shares decline presumably on absence of any new data on coronavirus vaccine candidate.

AZN : 55.38 (-0.05%)
MRK : 80.91 (-0.14%)
MRNA : 72.01 (-2.82%)
VRTX : 268.73 (-1.56%)
AWS Powers Moderna's Digital Biotechnology Platform to Develop New Class of Vaccines and Therapeutics

Today, Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), announced that Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering a new class of messenger RNA (mRNA) medicines,...

AMZN : 3,148.16 (-0.61%)
MRNA : 72.01 (-2.82%)
The Zacks Analyst Blog Highlights: Eli Lilly, Moderna, Pfizer, Sanofi, GlaxoSmithKline and BioNTech

The Zacks Analyst Blog Highlights: Eli Lilly, Moderna, Pfizer, Sanofi, GlaxoSmithKline and BioNTech

SNY : 50.91 (-1.16%)
PFE : 38.39 (-0.16%)
MRNA : 72.01 (-2.82%)
LLY : 153.00 (+0.05%)
GSK : 40.94 (+0.37%)
BNTX : 73.95 (-3.96%)
Companies Search for More Efficient Ways to Diagnose Viral Diseases

, /PRNewswire/ -- The pandemic has drastically changed the world's social and economic landscape, and it's unclear what the next steps are in combating the spread of the viral infection. The United States...

TOMDF : 0.1100 (+23.60%)
MRNA : 72.01 (-2.82%)
NVAX : 178.51 (+4.83%)
CODX : 24.21 (-5.91%)
IBIO : 3.69 (-2.89%)
Moderna (MRNA) Reports Q2 Loss, Tops Revenue Estimates

Moderna (MRNA) delivered earnings and revenue surprises of 13.89% and 110.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

MRNA : 72.01 (-2.82%)
Moderna: 2Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Moderna Inc. (MRNA) on Wednesday reported a loss of $116.7 million in its second quarter.

MRNA : 72.01 (-2.82%)
Moderna Reports Second Quarter 2020 Financial Results and Provides Business Updates

--Moderna has received approximately $400 million of customer deposits as of July 31, 2020 for potential supply of mRNA-1273

MRNA : 72.01 (-2.82%)
MMM : 161.44 (+1.96%)
AMGN : 238.17 (-1.05%)
JNJ : 148.03 (-0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MRNA with:

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

2nd Resistance Point 76.40
1st Resistance Point 74.20
Last Price 72.01
1st Support Level 70.61
2nd Support Level 69.22

See More

52-Week High 95.21
Last Price 72.01
Fibonacci 61.8% 63.60
Fibonacci 50% 53.84
Fibonacci 38.2% 44.08
52-Week Low 12.47

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar